Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway

Jemal, 2006, Cancer statistics, 2006, CA Cancer J. Clin., 56, 106, 10.3322/canjclin.56.2.106 Lehnert, 1994, Multidrug resistance in human cancer, J. Neurooncol., 22, 239, 10.1007/BF01052927 Zgurskaya, 2000, Multidrug resistance mechanisms: drug efflux across two membranes, Mol. Microbiol., 37, 219, 10.1046/j.1365-2958.2000.01926.x Anand, 2008, Curcumin and cancer: an “old-age” disease with an “age-old” solution, Cancer Lett., 267, 133, 10.1016/j.canlet.2008.03.025 Kuttan, 1985, Potential anticancer activity of turmeric (Curcuma longa), Cancer Lett., 29, 197, 10.1016/0304-3835(85)90159-4 Chen, 2008, Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1, Cancer Res., 68, 7428, 10.1158/0008-5472.CAN-07-6734 Pinlaor, 2009, Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant–antioxidant status in hamsters infected with Opisthorchis viverrini, Mol. Nutr. Food Res., 53, 1316, 10.1002/mnfr.200800567 Sandur, 2007, Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane), Free Radic. Biol. Med., 43, 568, 10.1016/j.freeradbiomed.2007.05.009 Li, 2007, Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer, Mol. Cancer Ther., 6, 1276, 10.1158/1535-7163.MCT-06-0556 Li, 2005, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis, Cancer, 104, 1322, 10.1002/cncr.21300 Sun, 2008, Curcumin (diferuloylmethane) alters the expression profiles of miRNAs in human pancreatic cancer cells, Mol. Cancer Ther., 7, 464, 10.1158/1535-7163.MCT-07-2272 Li, 2010, Regulation of miRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research, Pharm. Res., 10.1007/s11095-010-0105-y Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Chen, 2005, Real-time quantification of miRNAs by stem-loop RT-PCR, Nucleic Acids Res., 33, e179, 10.1093/nar/gni178 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 Liu, 2010, miRNA-31 functions as an oncogenic miRNA in mouse and human lung cancer cells by repressing specific tumor suppressors, J. Clin. Invest., 120, 1298, 10.1172/JCI39566 Raguz, 2008, Resistance to chemotherapy: new treatments and novel insights into an old problem, Br. J. Cancer, 99, 387, 10.1038/sj.bjc.6604510 Chiu, 2009, Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-κBp65 expression in breast cancer MDA-MB-231 cells, Int. J. Mol. Med., 23, 469 Johnson, 2009, Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling, Anticancer Res., 29, 3185 Chendil, 2004, Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3, Oncogene, 23, 1599, 10.1038/sj.onc.1207284 Sandur, 2009, Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-κB activity, Int. J. Radiat. Oncol. Biol. Phys., 75, 534, 10.1016/j.ijrobp.2009.06.034 Choi, 2008, Curcumin downregulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF-κB pathway, Cancer Lett., 259, 111, 10.1016/j.canlet.2007.10.003 Simoni, 2008, Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug-resistant cancer cells, Bioorg. Med. Chem. Lett., 18, 845, 10.1016/j.bmcl.2007.11.021 Labbozzetta, 2009, Curcumin as a possible lead compound against hormone-independent multidrug-resistant breast cancer, Ann. NY Acad. Sci., 1155, 278, 10.1111/j.1749-6632.2009.03699.x Karunagaran, 2007, Cell growth regulation, Adv. Exp. Med. Biol., 595, 245, 10.1007/978-0-387-46401-5_11 Li, 2009, Upregulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells, Cancer Res., 69, 6704, 10.1158/0008-5472.CAN-09-1298 Sun, 2009, Genistein inhibits growth of human uveal melanoma cells and affects miRNA-27a and target gene expression, Oncol. Rep., 22, 563 Zhou, 2008, MicroRNAs miR-186 and miR-150 downregulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript, J. Biol. Chem., 283, 28274, 10.1074/jbc.M802663200